Validation of a Novel Predictive Algorithm for Kidney Failure in Patients Suffering from Chronic Kidney Disease: The Prognostic Reasoning System for Chronic Kidney Disease (PROGRES-CKD).

artificial intelligence chronic kidney disease (CKD) end-stage kidney disease (ESKD) kidney replacement therapy (KRT) machine learning naïve Bayes classifiers precision medicine risk prediction

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
30 11 2021
Historique:
received: 28 10 2021
revised: 21 11 2021
accepted: 25 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

Current equation-based risk stratification algorithms for kidney failure (KF) may have limited applicability in real world settings, where missing information may impede their computation for a large share of patients, hampering one from taking full advantage of the wealth of information collected in electronic health records. To overcome such limitations, we trained and validated the Prognostic Reasoning System for Chronic Kidney Disease (PROGRES-CKD), a novel algorithm predicting end-stage kidney disease (ESKD). PROGRES-CKD is a naïve Bayes classifier predicting ESKD onset within 6 and 24 months in adult, stage 3-to-5 CKD patients. PROGRES-CKD trained on 17,775 CKD patients treated in the Fresenius Medical Care (FMC) NephroCare network. The algorithm was validated in a second independent FMC cohort (

Identifiants

pubmed: 34886378
pii: ijerph182312649
doi: 10.3390/ijerph182312649
pmc: PMC8656741
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Eur J Psychotraumatol. 2017 Jul 15;8(sup3):1341276
pubmed: 29038690
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):954-961
pubmed: 30975657
Med Educ. 2005 Sep;39(9):870-2
pubmed: 16150023
Heart. 2012 May;98(9):691-8
pubmed: 22397946
J Med Internet Res. 2016 Dec 16;18(12):e323
pubmed: 27986644
JAMA. 2016 Jan 12;315(2):164-74
pubmed: 26757465
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1011-1020
pubmed: 31196951
J Clin Epidemiol. 2013 Mar;66(3):268-77
pubmed: 23116690
Ann Intern Med. 2013 Apr 16;158(8):596-603
pubmed: 23588748
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Semin Nephrol. 2017 Mar;37(2):144-150
pubmed: 28410648
Nephrol Dial Transplant. 2021 Sep 27;36(10):1837-1850
pubmed: 33051669
Nephrol Dial Transplant. 2000;15 Suppl 3:8-13
pubmed: 11032351
J Am Soc Nephrol. 2019 Sep;30(9):1735-1745
pubmed: 31292197
Lancet Diabetes Endocrinol. 2019 Feb;7(2):128-139
pubmed: 30635226
J Am Soc Nephrol. 2014 Feb;25(2):390-8
pubmed: 24158983
Postgrad Med J. 1997 Aug;73(862):491-5
pubmed: 9307741
Methods Inf Med. 2004;43(1):83-8
pubmed: 15026844
BMJ. 2015 Jan 07;350:g7594
pubmed: 25569120
Nephrol Dial Transplant. 2017 May 1;32(5):752-755
pubmed: 28499028
Sci Rep. 2020 Jul 31;10(1):12920
pubmed: 32737361
JAMA. 2011 Apr 20;305(15):1553-9
pubmed: 21482743
Am J Kidney Dis. 2016 May;67(5):779-86
pubmed: 26725311
BMC Nephrol. 2019 Apr 26;20(1):142
pubmed: 31027481
BMC Nephrol. 2014 Aug 23;15:136
pubmed: 25150057
Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1072-7
pubmed: 25762523
Lancet. 2017 Mar 25;389(10075):1238-1252
pubmed: 27887750
Adv Chronic Kidney Dis. 2011 Nov;18(6):420-7
pubmed: 22098660
Nephrol Dial Transplant. 2020 Sep 1;35(9):1527-1538
pubmed: 30830157
J Diabetes Complications. 2017 Mar;31(3):624-630
pubmed: 28041817
Biol Psychiatry. 2009 Jul 1;66(1):25-32
pubmed: 19403118
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Am J Med. 2008 May;121(5 Suppl):S24-9
pubmed: 18440351
Acad Med. 2009 Aug;84(8):1022-8
pubmed: 19638766
G Ital Nefrol. 2016 Feb;33 Suppl 66:33.S66.11
pubmed: 26913879
Nephrol Dial Transplant. 2012 Apr;27(4):1454-60
pubmed: 21862458
Lancet. 2012 Jan 14;379(9811):165-80
pubmed: 21840587
Int J Artif Organs. 2002 Nov;25(11):1049-60
pubmed: 12487392
Med Princ Pract. 2017;26(2):101-107
pubmed: 28152529
PLoS One. 2016 Oct 4;11(10):e0164201
pubmed: 27701466
Artif Intell Med. 2016 Jan;66:41-52
pubmed: 26395654
Kidney Int. 2017 Apr;91(4):982-988
pubmed: 28187983
J Eval Clin Pract. 2006 Apr;12(2):132-9
pubmed: 16579821
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215
PLoS Med. 2012;9(11):e1001344
pubmed: 23185136

Auteurs

Francesco Bellocchio (F)

Clinical & Data Intelligence Systems-Advanced Analytics, Fresenius Medical Care Deutschland GmbH, 26020 Vaiano Cremasco, Italy.

Caterina Lonati (C)

Center for Preclinical Research, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Jasmine Ion Titapiccolo (J)

Clinical & Data Intelligence Systems-Advanced Analytics, Fresenius Medical Care Deutschland GmbH, 26020 Vaiano Cremasco, Italy.

Jennifer Nadal (J)

Department of Medical Biometry, Informatics, and Epidemiology (IMBIE), Faculty of Medicine, University of Bonn, 53113 Bonn, Germany.

Heike Meiselbach (H)

Department of Nephrology and Hypertension, Friedrich-Alexander University of Erlangen-Nürnberg, 91054 Erlangen, Germany.

Matthias Schmid (M)

Department of Medical Biometry, Informatics, and Epidemiology (IMBIE), Faculty of Medicine, University of Bonn, 53113 Bonn, Germany.

Barbara Baerthlein (B)

Medical Centre for Information and Communication Technology (MIK), University Hospital Erlangen, 91054 Erlangen, Germany.

Ulrich Tschulena (U)

Fresenius Medical Care, Deutschland GmbH, 61352 Bad Homburg, Germany.

Markus Schneider (M)

Department of Medical Biometry, Informatics, and Epidemiology (IMBIE), Faculty of Medicine, University of Bonn, 53113 Bonn, Germany.

Ulla T Schultheiss (UT)

Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, 79085 Freiburg, Germany.
Department of Medicine IV-Nephrology and Primary Care, Faculty of Medicine and Medical Center, University of Freiburg, 79085 Freiburg, Germany.

Carlo Barbieri (C)

Fresenius Medical Care, Deutschland GmbH, 61352 Bad Homburg, Germany.

Christoph Moore (C)

Fresenius Medical Care, Deutschland GmbH, 61352 Bad Homburg, Germany.

Sonja Steppan (S)

Fresenius Medical Care, Deutschland GmbH, 61352 Bad Homburg, Germany.

Kai-Uwe Eckardt (KU)

Department of Nephrology and Hypertension, Friedrich-Alexander University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.

Stefano Stuard (S)

Fresenius Medical Care, Deutschland GmbH, 61352 Bad Homburg, Germany.

Luca Neri (L)

Clinical & Data Intelligence Systems-Advanced Analytics, Fresenius Medical Care Deutschland GmbH, 26020 Vaiano Cremasco, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH